165 related items for PubMed ID: 1461951
1. Age and the dexamethasone suppression test: results from a broad unselected patient population.
Keitner GI, Ryan CE, Kohn R, Miller IW, Norman WH, Brown WA.
Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
[Abstract] [Full Text] [Related]
2. Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
Gwirtsman HE, Roy-Byrne P, Gitlin MJ, Halaris A, Ahles S.
J Affect Disord; 1985 Sep; 9(2):193-6. PubMed ID: 2932495
[Abstract] [Full Text] [Related]
3. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
Arana GW, Wilens TE, Baldessarini RJ.
Psychoneuroendocrinology; 1985 Sep; 10(1):49-60. PubMed ID: 4001277
[Abstract] [Full Text] [Related]
4. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
[Abstract] [Full Text] [Related]
5. HPA axis function and temperament in depression: a negative report.
Roy A.
Biol Psychiatry; 1996 Mar 01; 39(5):364-6. PubMed ID: 8704068
[Abstract] [Full Text] [Related]
6. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
Evans DL, Nemeroff CB, Haggerty JJ, Pedersen CA.
Psychoneuroendocrinology; 1987 Mar 01; 12(3):203-9. PubMed ID: 3615749
[Abstract] [Full Text] [Related]
7. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK.
Biol Psychiatry; 1987 Feb 01; 22(2):228-34. PubMed ID: 3028512
[No Abstract] [Full Text] [Related]
8. The dexamethasone suppression test in prepubertal depressed children.
Weller EB, Weller RA, Fristad MA, Preskorn SH, Teare M.
J Clin Psychiatry; 1985 Dec 01; 46(12):511-3. PubMed ID: 4066616
[Abstract] [Full Text] [Related]
9. Noradrenergic function and the cortisol response to dexamethasone in depression.
Rubin AL, Price LH, Charney DS, Heninger GR.
Psychiatry Res; 1985 May 01; 15(1):5-15. PubMed ID: 2989963
[Abstract] [Full Text] [Related]
10. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.
Axelson DA, Doraiswamy PM, Boyko OB, Rodrigo Escalona P, McDonald WM, Ritchie JC, Patterson LJ, Ellinwood EH, Nemeroff CB, Krishnan KR.
Psychiatry Res; 1992 Oct 01; 44(1):63-70. PubMed ID: 1461948
[Abstract] [Full Text] [Related]
11. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
Tajima-Pozo K, Montes-Montero A, Güemes I, González-Vives S, Díaz-Marsá M, Carrasco JL.
Endocrinol Nutr; 2013 Oct 01; 60(7):396-403. PubMed ID: 23623464
[Abstract] [Full Text] [Related]
12. Dexamethasone suppression test and sleep deprivation in endogenous depression.
Kuhs H.
J Affect Disord; 1985 Sep 01; 9(2):121-6. PubMed ID: 2932484
[Abstract] [Full Text] [Related]
13. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
Nelson WH, Orr WW, Shane SR, Stevenson JM.
J Clin Psychiatry; 1984 Mar 01; 45(3):120-1. PubMed ID: 6698943
[Abstract] [Full Text] [Related]
14. The dexamethasone suppression test in a general hospital psychiatric setting.
Warneke LB.
Can J Psychiatry; 1985 Dec 01; 30(8):614-8. PubMed ID: 4084903
[Abstract] [Full Text] [Related]
15. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
Magni G, Schifano F, De Leo D, De Dominicis MG, Garbin A, Zangaglia O.
Acta Psychiatr Scand; 1986 May 01; 73(5):511-4. PubMed ID: 3751656
[Abstract] [Full Text] [Related]
16. The dexamethasone suppression test and pituitary-adrenocortical function.
Brown WA, Keitner G, Qualls CB, Haier R.
Arch Gen Psychiatry; 1985 Feb 01; 42(2):121-3. PubMed ID: 3977539
[Abstract] [Full Text] [Related]
17. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Bagdy G, Rihmer Z, Frecska E, Szádóczky E, Arató M.
Psychoneuroendocrinology; 1986 Feb 01; 11(1):117-20. PubMed ID: 3704065
[Abstract] [Full Text] [Related]
18. Plasmatic vasopressin neurophysin in depression: basic levels and relations with HPA axis.
Laruelle M, Seghers A, Goffinet S, Bouchez S, Legros JJ.
Biol Psychiatry; 1990 Jun 01; 27(11):1249-63. PubMed ID: 2354230
[Abstract] [Full Text] [Related]
19. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, Katz MM, Robins E.
Acta Psychiatr Scand; 1992 Apr 01; 85(4):270-4. PubMed ID: 1595360
[Abstract] [Full Text] [Related]
20. Dexamethasone suppression test in psychiatric patients with psychoactive substance dependence.
Olivera AA, Fero D, Scibilia J.
Am J Drug Alcohol Abuse; 1991 Sep 01; 17(3):295-305. PubMed ID: 1928023
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
